Publicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (9)

2024

  1. Aberrant TIMP-1 production in tumor-associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma

    Cancer Science, Vol. 115, Núm. 5, pp. 1505-1519

2022

  1. Matrix Metalloproteinases and Their Inhibitors in Pulmonary Fibrosis: EMMPRIN/CD147 Comes into Play

    International Journal of Molecular Sciences, Vol. 23, Núm. 13

2020

  1. Interleukin-1β Modulation of the Mechanobiology of Primary Human Pulmonary Fibroblasts: Potential Implications in Lung Repair

    International journal of molecular sciences, Vol. 21, Núm. 22

2017

  1. Epithelial contribution to the profibrotic stiff microenvironment and myofibroblast population in lung fibrosis

    Molecular Biology of the Cell, Vol. 28, Núm. 26, pp. 3741-3755

2013

  1. Low prostaglandin E2 and cyclooxygenase expression in nasal mucosa fibroblasts of aspirin-intolerant asthmatics

    Respirology, Vol. 18, Núm. 4, pp. 711-717

2011

  1. Reduced expression of COXs and production of prostaglandin E2 in patients with nasal polyps with or without aspirin-intolerant asthma

    Journal of Allergy and Clinical Immunology, Vol. 128, Núm. 1, pp. 66-72.e1

2010

  1. A haplotype of cyclooxygenase-2 gene is associated with idiopathic pulmonary fibrosis

    Sarcoidosis Vasculitis and Diffuse Lung Diseases, Vol. 27, Núm. 2, pp. 121-130

2008

  1. Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression

    European Respiratory Journal, Vol. 32, Núm. 4, pp. 1004-1008

2007

  1. Experimental models for the study of pulmonary fibrosis: Current usefulness and future promise

    Archivos de Bronconeumologia, Vol. 43, Núm. 9, pp. 501-507